SeekingAlpha · Sep 3, 2026
Broadcom: Not Out Of The Woods, Just Cheaper (Rating Upgrade)
Broadcom Inc. stock is upgraded from sell to hold as AI ASIC margins fall but revenue accelerates. Click here to read this earnings update of AVGO.
OTC · ANTH
Anthera Pharmaceuticals, Inc.
Healthcare · Biotechnology
$0.00
Up+$0.00 (+0.00%)
Updated Sep 13, 2026, 3:56 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.62K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $0.00
- Volume
- 21K
- Avg. volume
- 5.56K
Price performance
ANTH price history
1M range · 3 trading sessions · Daily adjusted prices
ANTH closed at $0.00 after 3 trading sessions, down 100.00% for the selected period.
- Last close
- $0.00
- Period change
- -100.00%
- Period low
- $0.00
- Period high
- $0.00
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 2, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 21K |
| Aug 27, 2026 | $0.00 | $0.0001 | $0.00 | $0.00 | 1.49K |
| Aug 19, 2026 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 812 |
Latest ANTH news
The latest Smart Investors Daily articles mentioning ANTH.
Stock researchCompany · Overview
ANTH research
Overview
Company profile and research snapshot.
Company profile
ANTHERA PHARMS INC NEW
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 21, 2018 | Roth Capital | Buy | — |
| Dec 29, 2016 | Citigroup | Neutral | — |
| Dec 29, 2016 | Jefferies | Hold | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
